More Evidence Metformin May Be Neuroprotective More Evidence Metformin May Be Neuroprotective
Stopping metformin was linked to an increased risk for dementia diagnosis in a large cohort of adults with T2D, providing more evidence of the drug ’s potential neuroprotective effects.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 1, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Metformin May Help Young Patients With Bipolar Disorder Avoid Weight Gain
TUESDAY, Oct. 31, 2023 -- Taking the drug metformin– typically used for type 2 diabetes– can help counter weight gain in young people who are taking medication for bipolar disorder, according to a new trial.
While second-generation... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2023 Category: General Medicine Source Type: news
Dementia Incidence Increased With Termination of Metformin
FRIDAY, Oct. 27, 2023 -- Terminating metformin treatment is associated with an increased incidence of dementia, according to a study published online Oct. 25 in JAMA Network Open.
Scott C. Zimmerman, M.P.H., from the University of California in San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 27, 2023 Category: Pharmaceuticals Source Type: news
Have Diabetes? Quitting Metformin Could Take Toll on Your Brain
THURSDAY, Oct. 26, 2023 -- Millions of people with diabetes take the drug metformin to control their blood sugar levels.
Meant to be taken for the long term, new research now suggests that stopping it early may up the risk of developing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2023 Category: General Medicine Source Type: news
Another Study Highlights Metformin's Dementia Protection Properties
(MedPage Today) -- More evidence suggested that metformin may be protective against new-onset dementia in older adults with diabetes, a cohort study found.
Compared with routine metformin users, those who stopped the drug early for reasons other... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 25, 2023 Category: Psychiatry Source Type: news
Pregnant women can soon take anti-diabetes drug Metformin
The UK and some EU countries allow this drug for pregnant women and during the periconceptional phase. So far, doctors in India prescribe insulin for pregnant women. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 25, 2023 Category: Pharmaceuticals Source Type: news
Glenmark launches triple-drug combo for type 2 diabetes
Glenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, which combines Teneligliptin, Dapagliflozin, and Metformin, is priced at Rs 14 per tablet and aims to improve glycemic control in diabetic patients. The medication is expected to lower the daily cost of therapy by 30%, making it more affordable for patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 18, 2023 Category: Pharmaceuticals Source Type: news
Metformin, Weight Management to Stop Type 2 Diabetes in Kids Metformin, Weight Management to Stop Type 2 Diabetes in Kids
It may be possible to predict progression of type 2 diabetes in kids with prediabetes through a few important screening tests — notably A1c plus nonfasting glucose — and possibly stop it in its tracks.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 12, 2023 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Early Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 -- Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level≥5.1 mmol/L at gestation weeks 32 or 38 or insulin initiation, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2023 Category: Pharmaceuticals Source Type: news
Mixed Bag for Early Metformin in Gestational Diabetes
(MedPage Today) -- HAMBURG, Germany -- Giving metformin early on to women with gestational diabetes failed to show a statistically significant benefit for the phase III EMERGE trial's primary endpoint, but secondary outcomes did appear to favor... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - October 3, 2023 Category: OBGYN Source Type: news
Metformin Treatment Shows Benefit in Gestational Diabetes Metformin Treatment Shows Benefit in Gestational Diabetes
Women randomly assigned to metformin at diagnosis had improved blood glucose levels compared with placebo and were less likely to need insulin, but questions remain.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 3, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
First-Line Therapy in T2D: Has Metformin Been'Dethroned'? First-Line Therapy in T2D: Has Metformin Been'Dethroned'?
Joshua Neumiller, PharmD and Radica Alicic, MD, review the changing landscape in first-line therapy medications for type 2 diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 15, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Myoinositol With Metformin vs Metformin Monotherapy in PCOS Myoinositol With Metformin vs Metformin Monotherapy in PCOS
An RCT looked at the effects of metformin alone or combined with myoinositol in the treatment of PCOS. How do they compare?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Could Metformin Help Seniors Bounce Back After Surgery?
FRIDAY, July 28, 2023 -- The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.
Researchers found that metformin -- a drug that has been around for more than a half-century to regulate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 28, 2023 Category: General Medicine Source Type: news
Akums gets DCGI nod for triple combination diabetes medication
Akums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes medication. The drug combines Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 to provide better treatment without the need for multiple drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2023 Category: Pharmaceuticals Source Type: news
